NO20016155L - Indoloazepiner som vasopressinreseptorantagonister - Google Patents
Indoloazepiner som vasopressinreseptorantagonisterInfo
- Publication number
- NO20016155L NO20016155L NO20016155A NO20016155A NO20016155L NO 20016155 L NO20016155 L NO 20016155L NO 20016155 A NO20016155 A NO 20016155A NO 20016155 A NO20016155 A NO 20016155A NO 20016155 L NO20016155 L NO 20016155L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- vasopressin receptor
- indoloazepines
- ischemia
- cardiac
- Prior art date
Links
- KDDCNSWPVMLDHI-UHFFFAOYSA-N azepino[3,2-b]indole Chemical class C1=CC=CN=C2C3=CC=CC=C3N=C21 KDDCNSWPVMLDHI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002536 vasopressin receptor antagonist Substances 0.000 title abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 3
- 206010003225 Arteriospasm coronary Diseases 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010048962 Brain oedema Diseases 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000003890 Coronary Vasospasm Diseases 0.000 abstract 1
- 206010016807 Fluid retention Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 206010047163 Vasospasm Diseases 0.000 abstract 1
- 208000006752 brain edema Diseases 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000011634 coronary artery vasospasm Diseases 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13962899P | 1999-06-17 | 1999-06-17 | |
| US09/592,520 US6765004B1 (en) | 1999-06-17 | 2000-06-12 | Indoloazepines as vasopressin receptor antagonists |
| PCT/US2000/016549 WO2000078762A1 (en) | 1999-06-17 | 2000-06-15 | Indoloazepines as vasopressin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20016155D0 NO20016155D0 (no) | 2001-12-17 |
| NO20016155L true NO20016155L (no) | 2002-02-15 |
Family
ID=26837417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20016155A NO20016155L (no) | 1999-06-17 | 2001-12-17 | Indoloazepiner som vasopressinreseptorantagonister |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6765004B1 (no) |
| EP (1) | EP1214323B1 (no) |
| JP (1) | JP2003502426A (no) |
| CN (1) | CN1399638A (no) |
| AT (1) | ATE282621T1 (no) |
| AU (1) | AU774768B2 (no) |
| BR (1) | BR0012294A (no) |
| CA (1) | CA2375268A1 (no) |
| DE (1) | DE60015997T2 (no) |
| DK (1) | DK1214323T3 (no) |
| ES (1) | ES2233402T3 (no) |
| HU (1) | HUP0201725A3 (no) |
| IL (1) | IL147130A0 (no) |
| MX (1) | MXPA01013286A (no) |
| NO (1) | NO20016155L (no) |
| NZ (1) | NZ516209A (no) |
| PL (1) | PL352998A1 (no) |
| PT (1) | PT1214323E (no) |
| TR (1) | TR200200560T2 (no) |
| WO (1) | WO2000078762A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US8567448B2 (en) * | 2007-12-26 | 2013-10-29 | Smart Pipe Company, Inc. | Methods and systems for in situ pipe lining |
| US8828989B2 (en) | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
| CN112107568B (zh) * | 2019-06-19 | 2022-03-25 | 北京龙嘉博创医药科技有限公司 | 二芳基酰胺类化合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3314942A (en) * | 1964-08-06 | 1967-04-18 | Upjohn Co | 3, 4, 5, 6-tetrahydro-1h-azepino(4, 3, 2-cd) indoles |
| US3249623A (en) * | 1964-09-24 | 1966-05-03 | Upjohn Co | Derivatives of 3, 4, 5, 6-tetrahydro-1h-azepino [4, 3, 2-cd] indoles |
| BE795451A (fr) * | 1972-02-23 | 1973-08-16 | Pfizer | Agents hypoglycemiants aza indoliques tricycliques |
| DE3525564A1 (de) * | 1985-07-15 | 1987-02-05 | Schering Ag | Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| JPS6434988A (en) * | 1987-07-30 | 1989-02-06 | Kissei Pharmaceutical | Azepinoindole derivative |
| GB9307527D0 (en) | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
| NZ268671A (en) * | 1993-07-21 | 1997-09-22 | Yamanouchi Pharma Co Ltd | Fused benzazepin-1-yl-carbonylphenyl derivatives |
| DE4438178A1 (de) * | 1994-10-26 | 1996-05-02 | Bayer Ag | N-Methyl-N-isopropyl-heteroaryloxyacetamide |
-
2000
- 2000-06-12 US US09/592,520 patent/US6765004B1/en not_active Expired - Lifetime
- 2000-06-15 EP EP00941464A patent/EP1214323B1/en not_active Expired - Lifetime
- 2000-06-15 JP JP2001504928A patent/JP2003502426A/ja active Pending
- 2000-06-15 CN CN00811602A patent/CN1399638A/zh active Pending
- 2000-06-15 HU HU0201725A patent/HUP0201725A3/hu unknown
- 2000-06-15 CA CA002375268A patent/CA2375268A1/en not_active Abandoned
- 2000-06-15 PT PT00941464T patent/PT1214323E/pt unknown
- 2000-06-15 WO PCT/US2000/016549 patent/WO2000078762A1/en active IP Right Grant
- 2000-06-15 MX MXPA01013286A patent/MXPA01013286A/es unknown
- 2000-06-15 IL IL14713000A patent/IL147130A0/xx unknown
- 2000-06-15 AU AU56170/00A patent/AU774768B2/en not_active Ceased
- 2000-06-15 PL PL00352998A patent/PL352998A1/xx unknown
- 2000-06-15 DE DE60015997T patent/DE60015997T2/de not_active Expired - Fee Related
- 2000-06-15 DK DK00941464T patent/DK1214323T3/da active
- 2000-06-15 ES ES00941464T patent/ES2233402T3/es not_active Expired - Lifetime
- 2000-06-15 AT AT00941464T patent/ATE282621T1/de not_active IP Right Cessation
- 2000-06-15 TR TR2002/00560T patent/TR200200560T2/xx unknown
- 2000-06-15 BR BR0012294-7A patent/BR0012294A/pt not_active IP Right Cessation
- 2000-06-15 NZ NZ516209A patent/NZ516209A/xx unknown
-
2001
- 2001-12-17 NO NO20016155A patent/NO20016155L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0201725A3 (en) | 2003-09-29 |
| ATE282621T1 (de) | 2004-12-15 |
| IL147130A0 (en) | 2002-08-14 |
| ES2233402T3 (es) | 2005-06-16 |
| NZ516209A (en) | 2004-01-30 |
| TR200200560T2 (tr) | 2003-01-21 |
| EP1214323B1 (en) | 2004-11-17 |
| PL352998A1 (en) | 2003-09-22 |
| NO20016155D0 (no) | 2001-12-17 |
| DE60015997T2 (de) | 2005-12-01 |
| JP2003502426A (ja) | 2003-01-21 |
| DK1214323T3 (da) | 2005-01-10 |
| MXPA01013286A (es) | 2003-08-20 |
| US6765004B1 (en) | 2004-07-20 |
| CN1399638A (zh) | 2003-02-26 |
| WO2000078762A1 (en) | 2000-12-28 |
| AU5617000A (en) | 2001-01-09 |
| EP1214323A1 (en) | 2002-06-19 |
| CA2375268A1 (en) | 2000-12-28 |
| PT1214323E (pt) | 2005-02-28 |
| HUP0201725A2 (en) | 2002-10-28 |
| AU774768B2 (en) | 2004-07-08 |
| DE60015997D1 (de) | 2004-12-23 |
| BR0012294A (pt) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY128065A (en) | Tricyclic benzodiazepines as vasopressin receptor antagonists | |
| DK1307430T3 (da) | Ikke-peptidsubstituerede spirobenzoazepiner som vasopressin-antagonister | |
| CY1112270T1 (el) | Σπειρο βενζαζεπινες χρησιμες ως ανταγωνιστες αγγειοπιεσινης | |
| NO20060247L (no) | Substituerte spirobenzazepiner | |
| DK1214323T3 (da) | Indoloazepiner som vasopressinreceptorantagonister | |
| WO2006049984A3 (en) | Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists | |
| MXPA02004513A (es) | Benzotiazefinas sustituidas no peptidicas como antagonistas de vasopresina. | |
| DE69324910D1 (de) | Triazolopyrimidinderivate als angiotensin-ii rezeptor antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |